152 related articles for article (PubMed ID: 33475023)
41. Effect of MeCP2 on TGF- β1-induced Extracellular Matrix Production in Nasal Polyp-derived Fibroblasts.
Shin JM; Um JY; Lee SA; Park IH; Lee SH; Lee HM
Am J Rhinol Allergy; 2018 Jul; 32(4):228-235. PubMed ID: 29676176
[TBL] [Abstract][Full Text] [Related]
42. [Influences of human dermis derived mesenchymal stem cells on α-SMA and DCN expressions of hypertrophic scars fibroblasts].
Zhang W; Deng C; Guo C; Nie K; Tang X; Wei Z; Wang D
Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Jul; 32(4):285-92. PubMed ID: 30044575
[TBL] [Abstract][Full Text] [Related]
43. Upregulation of the Wnt/beta-catenin pathway induced by transforming growth factor-beta in hypertrophic scars and keloids.
Sato M
Acta Derm Venereol; 2006; 86(4):300-7. PubMed ID: 16874413
[TBL] [Abstract][Full Text] [Related]
44. Dynamic biological changes in fibroblasts during hypertrophic scar formation and regression.
Chun Q; ZhiYong W; Fei S; XiQiao W
Int Wound J; 2016 Apr; 13(2):257-62. PubMed ID: 24802644
[TBL] [Abstract][Full Text] [Related]
45. Growth Differentiation Factor-9 Promotes Fibroblast Proliferation and Migration in Keloids through the Smad2/3 Pathway.
Jiang Z; Yu Q; Xia L; Zhang Y; Wang X; Wu X; Gao Z
Cell Physiol Biochem; 2016; 40(1-2):207-218. PubMed ID: 27855376
[TBL] [Abstract][Full Text] [Related]
46. TEM1/endosialin/CD248 promotes pathologic scarring and TGF-β activity through its receptor stability in dermal fibroblasts.
Hong YK; Lin YC; Cheng TL; Lai CH; Chang YH; Huang YL; Hung CY; Wu CH; Hung KS; Ku YC; Ho YT; Tang MJ; Lin SW; Shi GY; McGrath JA; Wu HL; Hsu CK
J Biomed Sci; 2024 Jan; 31(1):12. PubMed ID: 38254097
[TBL] [Abstract][Full Text] [Related]
47. Keloids are transcriptionally distinct from normal and hypertrophic scars.
Walter AS; Stocks M; Akova E; Gauglitz G; Hartmann D; Aszodi A; Böcker W; Saller MM; Volkmer E
Eur J Dermatol; 2023 Dec; 33(6):604-611. PubMed ID: 38465540
[TBL] [Abstract][Full Text] [Related]
48. [Expressions of TGF-betaR I, Smad2, Smad3 and Smad7 in keloids].
Sun Y; Song JX; Wang ZM; Chen JP; Chen Y; Tan XJ; Bai J
Zhonghua Zheng Xing Wai Ke Za Zhi; 2006 Sep; 22(5):368-70. PubMed ID: 17144456
[TBL] [Abstract][Full Text] [Related]
49. [Expression of thymosin beta 4 mRNA expression in keloid tissues and fibroblasts cultured from keloid and its significance].
Nie FF; Wu JQ; Qin ZL
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Feb; 17(2):80-3. PubMed ID: 15698487
[TBL] [Abstract][Full Text] [Related]
50. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids.
Ulrich D; Ulrich F; Unglaub F; Piatkowski A; Pallua N
J Plast Reconstr Aesthet Surg; 2010 Jun; 63(6):1015-21. PubMed ID: 19464975
[TBL] [Abstract][Full Text] [Related]
51. Effect of the abrogation of TGF-beta1 by antisense oligonucleotides on the expression of TGF-beta-isoforms and their receptors I and II in isolated fibroblasts from keloid scars.
Bran GM; Goessler UR; Schardt C; Hormann K; Riedel F; Sadick H
Int J Mol Med; 2010 Jun; 25(6):915-21. PubMed ID: 20428796
[TBL] [Abstract][Full Text] [Related]
52. Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts.
Mun JH; Kim YM; Kim BS; Kim JH; Kim MB; Ko HC
Wound Repair Regen; 2014; 22(1):125-33. PubMed ID: 24471776
[TBL] [Abstract][Full Text] [Related]
53. [The expression of periostin in hyperplasic scars and the relations to TGF-beta1 and its receptors].
Wang Q; Nie FF; Zhao X; Qin ZL
Zhonghua Zheng Xing Wai Ke Za Zhi; 2007 May; 23(3):229-32. PubMed ID: 17649947
[TBL] [Abstract][Full Text] [Related]
54. [Experimental study of actin and myosin in the scar tissue].
Zhang Q; Qian YL; Cui L
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2001 Jan; 15(1):32-5. PubMed ID: 12563927
[TBL] [Abstract][Full Text] [Related]
55. [Variations of lipid peroxidation products and copper, zinc-superoxide dismutase in pathological scars].
Li W; Cen Y; Wang H; Chen W; Liu D
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Jul; 22(7):838-41. PubMed ID: 18681286
[TBL] [Abstract][Full Text] [Related]
56. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
Fujiwara M; Muragaki Y; Ooshima A
Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
[TBL] [Abstract][Full Text] [Related]
57. Vascularization pattern in hypertrophic scars and keloids: a stereological analysis.
Amadeu T; Braune A; Mandarim-de-Lacerda C; Porto LC; Desmoulière A; Costa A
Pathol Res Pract; 2003; 199(7):469-73. PubMed ID: 14521263
[TBL] [Abstract][Full Text] [Related]
58. FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach.
Wu CS; Wu PH; Fang AH; Lan CC
Br J Dermatol; 2012 Sep; 167(3):532-41. PubMed ID: 22540338
[TBL] [Abstract][Full Text] [Related]
59. Effects of miR-214 on adenosine A2A receptor and carboxymethyl chitosan nanoparticles on the function of keloid fibroblasts and their mechanisms.
Du Y; Liu J; Hao Q; Wang S; Zhang A; Li Y; Feng N
Sci Rep; 2024 Feb; 14(1):4896. PubMed ID: 38418830
[TBL] [Abstract][Full Text] [Related]
60. [Expression and significance of mRNA and protein of eIF4E, p-eIF4E and MCl-1 in pathological scar].
Wu WY; Zhang LT; Zheng ZF; Zhu SZ; Wang ZY
Zhonghua Zheng Xing Wai Ke Za Zhi; 2012 Sep; 28(5):360-5. PubMed ID: 23259313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
